Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study

ImportanceDespite people with impaired immune competence due to an underlying disease or ongoing therapy, hereinafter frail patients, are (likely to be) the first to be vaccinated, they were usually excluded from clinical trials.ObjectiveTo report adverse reactions of frail patients after receipt of...

Full description

Bibliographic Details
Main Authors: Serena Di Cosimo, Maria Teresa Lupo-Stanghellini, Massimo Costantini, Renato Mantegazza, Fabio Ciceri, Carlo Salvarani, Pier Luigi Zinzani, Alberto Mantovani, Gennaro Ciliberto, Antonio Uccelli, Fausto Baldanti, Giovanni Apolone, Sabina Delcuratolo, Aldo Morrone, Franco Locatelli, Chiara Agrati, Nicola Silvestris
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1002168/full